Cytokinetics, Inc. (CYTK)

[H2R]

SoS article after Edaravone FDA approval

I asked Smith on Stock his thoughts about the approval and he put together an article for his registered members:

https://smithonstocks.com/cytokinetics-what-are-the-implications-for-tirasemtiv-following-the-approval-of-radicava-edaravone-for-als-cytk-buy-15-40/

Still a buy for SoS;